Skip to main content

    Roundup of Ocular Oncology/Pathology Subspecialty Day

    AAO 2023
    Ocular Pathology/Oncology

    Dr. Claudia Maria Prospero Ponce, co-chair of Ocular Oncology/Pathology Subspecialty Day 2023, sat down with Dr. Basil Williams to discuss highlights. This year's program was modeled on "myths vs realities." Popular topics included retinoblastoma and diversity, equity, and inclusion.

    Financial Disclosures: Dr. Basil Williams discloses financial relationships with Alimera Sciences, Allergan, Castle Biosciences, EyePoint Pharmaceuticals, Genentech, Immunocore, Regeneron Pharmaceuticals (Consultant/Advisor); Lumata Health (Private Equity/Stock Holder). Dr. Claudia Maria Prospera Ponce discloses no financial relationships.